alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                                                    EXHIBIT 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002



I, C. Christian Winkle, President and Chief Executive Officer of Mariner
Health Care, Inc. (the "Company"), certify, pursuant to section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. section 1350, that:

(1)   the Quarterly Report on Form 10-Q of the Company for the quarterly
      period ended June 30, 2003 (the "Report") fully complies with the
      requirements of sections 13(a) or 15(d) of the Securities Exchange Act of
      1934; and

(2)   the information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.

Date:       August 14, 2003

/s/ C. Christian Winkle
----------------------------------
C. Christian Winkle
President and
Chief Executive Officer (Principal
Executive Officer)
AIR RESOURCES BOARD

VENTURA COUNTY APCD RULE EVALUATION FORM - Page 1

I. GENERAL INFORMATION

District: Ventura County APCD Rule No.: 67 Date / Amended/Repealed: June 12, 2012

Rule Title: Vacuum Producing Devices

Date Submitted to ARB: October 18, 2012 If an Amended Rule, Date Last Amended: Not Applicable

Is the Rule Intended to be Sent to the U.S. EPA as a SIP Revision? (X) Yes ( ) No If NO, do not complete remainder of form.

District Contact: Stan Cowen Phone No.: 805/645-1408

Narrative Summary of New Rule or Rule Changes: ( ) New Rule ( ) Amended (X) Repealed

Pollutant(s) Regulated by the Rule (Circle): ROG NOx SO2 PM10 CO TAC

II. EFFECT ON EMISSIONS

Complete this section ONLY for rules that, when implemented, will result in quantifiable changes in emission. Attach reference(s) for emission factor(s) and other 

information. Attach calculation sheet showing how the emissions information provided below was determined. See staff report Appendix A for emission calculations.

Net Effect on Emissions: ( ) Increase( ) Decrease ( X ) N/A No impact on emissions.

III. SOURCES/ATTAINMENT STATUS

District is: ( ) Attainment(X) Nonattainment ( ) Split

Approximate Total Number of Small (<100 TPY) Sources Controlled by Rule: None

Percent in Nonattainment Area: Not Applicable

Number of Large (>100 TPY) Sources Controlled: None Percent in Nonattainment Area: Not Applicable

IV. EMISSION REDUCTION TECHNOLOGY

Not Applicable

V. OTHER REQUIREMENTS

Not Applicable

VI. IMPACT ON AIR QUALITY PLAN

(X) No Impact( ) Impacts RFP ( ) Impacts attainment

Discussion: The repeal of Rule 67 will have no impact on emissions because it does not apply to any sources.
# Fourth Court of Appeals **San Antonio, Texas**

JUDGMENT

No. 04

- 22

- 00044

- CV

IN THE INTEREST OF D.G. JR. , and J.A.G., Children

From the 166th Judicial District Court

, Bexar County, Texas Trial Court No. 2020

- PA

- 01811 Honorable Charles E. Montemayor , Judge Presiding

BEFORE CHIEF JUSTICE MARTINEZ
, JUSTICE ALVAREZ , AND JUSTICE WATKINS

In accordance with this court’s opinion of this date, the trial court’s order of termination is AFFIRMED. It is ORDERED that no costs be assessed against appe llant in relation to this appeal because s he is presumed indigent under Texas Family Code section 107.013(e).

SIGNED June 1, 2022.

_____________________________ Beth Watkins, Justice
```

[Federal Register Volume 87, Number 19 (Friday, January 28, 2022)]
[Notices]
[Page 4634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01744]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Support for Research Excellence--
First Independent Research (SuRE-First) Award (R16--Clinical Trial 
Not Allowed).
    Date: February 25, 2022.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F36, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Noton K. Dutta, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F36, 
Rockville, MD 20852, 240-669-2857, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 25, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-01744 Filed 1-27-22; 8:45 am]
BILLING CODE 4140-01-P
```
**Exhibit 31.2****CERTIFICATION**I, Julia A. Fratianne, certify that: 1. I have reviewed this annual report on Form 10-K of Applied Innovation Inc.;  2. Based on my knowledge, this annual report does not contain any untrue statementof a material fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respects thefinancial condition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;  4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in ExchangeAct Rules 13a-15(e) and 15d-15(e)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; and  c) Disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’s mostrecent fiscal quarter (the registrant’s fourth fiscal quarter in the case of anannual report) that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting;and 5. The registrant’s other certifying officer and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of registrant’s board of directors (orpersons performing the equivalent functions): a) All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and  b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’s internal controlover financial reporting.Date:March 23, 2007       /s/ Julia A. Fratianne         Julia A. Fratianne    Vice President, Chief Financial Officer and Treasurer
CERTIFICATION
  1.
    
    I have reviewed this quarterly report on Form 10-Q of PowerSecure International, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:




---



##### 



5.
    
    The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
   Date:  August 6, 2009
    /s/ Christopher T. HutterChristopher T. HutterVice President, Chief Financial Officer,
Treasurer and Assistant Secretary
[ARTICLE] 9
[MULTIPLIER] 1000
<TABLE>
<S>                             <C>
[PERIOD-TYPE]                   6-MOS
[FISCAL-YEAR-END]                          DEC-31-1997
[PERIOD-END]                               JUN-30-1997
[CASH]                                          77,815
[INT-BEARING-DEPOSITS]                               0
[FED-FUNDS-SOLD]                                     0
[TRADING-ASSETS]                                     0
[INVESTMENTS-HELD-FOR-SALE]                    660,836
[INVESTMENTS-CARRYING]                          92,870
[INVESTMENTS-MARKET]                            93,486
[LOANS]                                      2,612,869
[ALLOWANCE]                                     25,960
[TOTAL-ASSETS]                               3,602,227
[DEPOSITS]                                   2,986,514
[SHORT-TERM]                                   112,927
[LIABILITIES-OTHER]                            151,219
[LONG-TERM]                                     20,061
[PREFERRED-MANDATORY]                                0
[PREFERRED]                                          0
[COMMON]                                           157
[OTHER-SE]                                     331,349
[TOTAL-LIABILITIES-AND-EQUITY]               3,602,227
[INTEREST-LOAN]                                106,396
[INTEREST-INVEST]                               23,003
[INTEREST-OTHER]                                   649
[INTEREST-TOTAL]                               130,048
[INTEREST-DEPOSIT]                              61,027
[INTEREST-EXPENSE]                              63,562
[INTEREST-INCOME-NET]                           66,486
[LOAN-LOSSES]                                    3,600
[SECURITIES-GAINS]                                 255
[EXPENSE-OTHER]                                 40,012
[INCOME-PRETAX]                                 29,640
[INCOME-PRE-EXTRAORDINARY]                           0
[EXTRAORDINARY]                                      0
[CHANGES]                                            0
[NET-INCOME]                                    18,758
[EPS-PRIMARY]                                     1.35
[EPS-DILUTED]                                     1.35
[YIELD-ACTUAL]                                    3.97
[LOANS-NON]                                     22,272
[LOANS-PAST]                                     7,383
[LOANS-TROUBLED]                                     0
[LOANS-PROBLEM]                                      0
[ALLOWANCE-OPEN]                                24,114
[CHARGE-OFFS]                                    2,535
[RECOVERIES]                                       781
[ALLOWANCE-CLOSE]                               25,960
[ALLOWANCE-DOMESTIC]                            21,226
[ALLOWANCE-FOREIGN]                                  0
[ALLOWANCE-UNALLOCATED]                          4,734
</TABLE>
# United States Court **of Appeals**  **f or the Fifth Circuit** 

No. 22

- 10200 Summary Calendar

**United States of America,** Plaintiff

— Appellee **,**

versus **Carlos Alberto Ayala,** Defendant

— Appellant

**.**

Appeal from the United States District Court for the Northern District of Texas USDC No. 6:21

- CR

- 47

- 1

Before **Wiener, Elrod,** and **Engelhardt,** Circuit Judges

**. Per Curiam**  **:** * The attorney appointed to represent Defendant

- Appellant Carlos Alberto Ayala has moved for leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Ayala has filed a response , a request

* Pursuant to **5th Cir cuit**  **R ule**  47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in **5th Cir cuit**  **R ule**  47.5.4. United States Court of Appeals Fifth Circuit 

### FILED September 23, 2022 Lyle W. Cayce Clerk Case: 22-10200 Document: 00516482319 Page: 1 Date Filed: 09/23/2022No. 22

- 10200

2 for appointment of substitute counsel , and a motion for leave to file an additional response , which is incorporated in the motion for leave

. His motion for leave to file an additional response is **GRANTED**

. We have reviewed counsel’s brief and the relevant portions of the record reflected therein , as well as Ayala ’s response s
. The record is not sufficiently developed to allow us to make a fair evaluation of Ayala’s claims of ineffectiv e assistance of counsel; we therefore decline to consider the claims , but without prejudice to collateral review. See United States v. Isgar , 739 F.3d 829, 841 (5th Cir. 2014). We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. C ounsel’s motion for leave to withdraw is therefore **GRANTED** , counsel is excused from further responsibilities herein, and Ayala’s appeal is **DISMISSED**

. See **5th Cir. R**

**.** 42. 2 . Ayala’s motion for appointment of new coun sel is **DENIED** as untimely

**.** United States v. Wagner , 158 F.3d 901, 902

– 03 (5th Cir. 1998)

. Case: 22-10200 Document: 00516482319 Page: 2 Date Filed: 09/23/2022
EXHIBIT 32: Rule 13a-14(b) Certification

The undersigned officer certifies that this report fully complies with
the requirements of Section 13(a) of the Securities Exchange Act of 1934,
and that the information contained in the report fairly presents, in all
material respects, the financial condition and results of operations of
Headliners Entertainment Group, Inc.

A signed original of this written statement required by Section 906 has
been provided to Headliners Entertainment Group, Inc. and will be
retained by Headliners Entertainment Group, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.

Date: February 21, 2006        /s/ Eduardo Rodriguez
                               -------------------------------------------
                               Eduardo Rodriguez, Chief Executive Officer,
                                and Principal Financial Officer
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

ODYSSEY MARINE EXPLORATION, INC.

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I hereby certify that, to the best of my knowledge, the annual report on Form 10-K of Odyssey Marine Exploration, Inc. for the period ending
December 31, 2008, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ----------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations of Odyssey Marine Exploration, Inc.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                                                                  
|------------------------------------------------------------------
|/S/ Gregory P. Stemm                                              
|Gregory P. Stemm Chairman of the Board and Chief Executive Officer

March 11, 2009

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Odyssey Marine Exploration, Inc. and will be retained by Odyssey Marine Exploration, Inc.
and furnished to the Securities and Exchange Commission upon request.
<PAGE>

EXHIBIT 11

                             DURA PHARMACEUTICALS, INC.
                 STATEMENTS RE COMPUTATIONS OF NET INCOME PER SHARE
<TABLE>
<CAPTION>
                                                         THREE MONTHS ENDED
                                                             MARCH 31,
                                                    -------------------------
                                                       1997            1998
                                                    -------------------------
<S>                                                 <C>               <C>
                                                            (UNAUDITED)
NET INCOME PER SHARE - BASIC

Net Income......................................    $8,786,698       $ 7,164,010
                                                    ----------       -----------
                                                    ----------       -----------
Weighted Average Number of Common and Common
  Equivalent Shares:
    Common stock................................    43,351,112        45,974,948
    Stock options...............................
    Warrants....................................
                                                    ----------       -----------
      Total.....................................    43,351,112        45,974,948
                                                    ----------       -----------
                                                    ----------       -----------
Net Income per Share............................    $     0.20         $    0.16
                                                    ----------       -----------
                                                    ----------       -----------

NET INCOME PER SHARE - DILUTED
Net Income......................................    $8,786,698        $7,164,010
                                                    ----------       -----------
                                                    ----------       -----------

Weighted Average Number of Common and Common
  Equivalent  Shares Assuming Issuance of All
   Dilutive Contingent Shares:
     Common stock...............................    43,351,112        45,974,948
     Stock options..............................     1,174,639           833,354
     Warrants...................................     2,714,066         1,714,750
                                                    ----------       -----------
       Total....................................    47,239,817        48,523,052
                                                    ----------       -----------
                                                    ----------       -----------

Net Income per Share............................    $     0.19       $      0.15
                                                    ----------       -----------
                                                    ----------       -----------
</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                  1,000
       
<S>                                     <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                       DEC-31-1999
<PERIOD-START>                          JAN-01-1999
<PERIOD-END>                            MAR-31-1999
<CASH>                                       12,843
<SECURITIES>                                941,820
<RECEIVABLES>                                31,173
<ALLOWANCES>                                      0
<INVENTORY>                                       0
<CURRENT-ASSETS>                                  0
<PP&E>                                            0
<DEPRECIATION>                                    0
<TOTAL-ASSETS>                            1,352,941
<CURRENT-LIABILITIES>                             0
<BONDS>                                     150,777
<PREFERRED-MANDATORY>                             0
<PREFERRED>                                       0
<COMMON>                                      3,990
<OTHER-SE>                                  671,514
<TOTAL-LIABILITY-AND-EQUITY>              1,352,941
<SALES>                                           0
<TOTAL-REVENUES>                             44,443
<CGS>                                             0
<TOTAL-COSTS>                               (27,070)
<OTHER-EXPENSES>                             (4,683)
<LOSS-PROVISION>                                (13)
<INTEREST-EXPENSE>                           (2,444)
<INCOME-PRETAX>                              19,625
<INCOME-TAX>                                  1,472
<INCOME-CONTINUING>                          18,153
<DISCONTINUED>                                   (0)
<EXTRAORDINARY>                                  (0)
<CHANGES>                                        (0)
<NET-INCOME>                                 18,153
<EPS-PRIMARY>                                  0.48
<EPS-DILUTED>                                  0.46
        


</TABLE>
EXHIBIT 32.1





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Aethlon Medical, Inc. (the “Registrant”) on Form 10-Q for the three month period ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof, I, James A. Joyce, Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





1.Based on my knowledge, the Quarterly Report on Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and





2.The information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Aethlon Medical, Inc.








Dated: August 22, 2011
/s/ JAMES A. JOYCEJames A. JoyceChief Executive OfficerAethlon Medical, Inc.





A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Aethlon Medical, Inc. and will be retained by Aethlon Medical, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.